Testing Participation in BRCA1/2-Positive Families: Initiator Role of Index Cases

Genetic Testing

Volumn 7, Issue 3, 2003, Pages 225-233

  Blandy, Cécile ^a   Chabal, Françoise ^b   Stoppa Lyonnet, Dominique ^a   Julian Reynier, Claire ^b  

^a INSTITUT CURIE   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; AGED; ARTICLE; AVOIDANCE BEHAVIOR; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE TRANSMISSION; DNA DETERMINATION; FEAR; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDICAL INFORMATION; ONCOGENE; OVARY CANCER; PATIENT SATISFACTION; QUESTIONNAIRE; SOCIAL SUPPORT;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADULT; ATTITUDE TO HEALTH; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT EDUCATION; PATIENT PARTICIPATION;

EID: 0242266947     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703322537241     Document Type: Article

References (29)

1. ANDRYKOWSKI, M.A., LIGHTNER, R., STUDTS, J.L., and MUNN, R.K. (1997). Hereditary cancer risk notification and testing: how interested is the general population? J. Clin. Oncol. 15, 2139-2148.
2. BIESECKER, B.B., ISHIBE, N., HADLEY, D.W., GIAMBARRESI, T.R., KASE, R.G., LERMAN, C., and STRUEWING J.P. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am. J. Med. Genet. 93, 257-263.
3. CAPPELLI, M., SURH, L., HUMPHREYS, L., VERMA, S., LOGAN, D., HUNTER, A., and ALLANSON, J. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin. Genet. 55, 419-430.
4. DECRUYENAERE, M., EVERS-KIEBOOMS, G., DENAYER, L., WELKENHUYSEN, M., CLAES, E., LEGIUS, E., and DEMYT-TENAERE, K. (2000). Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. Eur. J. Hum. Genet. 8, 130-136.
5. DUDOK DE WIT, A.C., TIBBEN, A., FRETS, P.G., MEIJERS-HEIJBOER, E.J., DEVILEE, P., KLIJN, J.G.M., OOSTERWIJK, J.C., and NIERMEIJER, M.F. (1997). BRCA1 in the family: a case description of the psychological implications. Am. J. Med. Genet. 7, 63-71.
6. EVANS, D.G.R., MAHER, E.R., MACLEOD, R., DAVIES, D.R., and CRAUFURD, D. (1997). Uptake of genetic testing for cancer predisposition. J. Med. Genet. 34, 746-748.
7. EVANS, D.G.R., BURNELL, L.D., HOPWOOD, P., and HOWELL, A. (1993). Perception of risk in women with a family history of breast cancer. Br. J. Cancer 67, 612-614.
8. EVANS, D.G.R., BLAIR, V., GREENHALGH, R., HOPWOOD, P., and HOWELL, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br. J. Cancer 70, 934-938.
9. FRENCH NATIONAL CONSULTATIVE ETHICS COMMITTEE, (1995). Avis 46. http://www.ccne-ethique.fr
10. GAUTHIER, J., and BOUCHARD, S. (1993). Adaptation Canadienne-Franç aise de la forme révisée du State Trait Anxiety Inventory de Spielberger. Revue Canadienne des Sciences du Comportement 25, 559-589.
11. GELLER, G., DOKSUM, T., BERNHARDT, B.A., and METZ, S.A. (1999). Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism and family involvement on women's decisions. Cancer Epidemiol Biomarkers Prev. 8, 377-383.
12. HOROWITZ, M., WILNER, M., and ALVAREZ, W. (1979). Impact of Event Scale: a measure of subjective stress. Psychosom. Med. 41, 209-218.
13. JACOBSEN, P.B., VALDIMARSDOTTIR, H.B., BROWN, K.L., and OFFIT, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom. Med. 59, 459-466.
14. JULIAN-REYNIER, C., EISINGER, F., VENNIN, P., CHABAL, F., AURRAN, Y., NOGUÈS, C., BIGNON, J.Y., MACHELARD-ROUMAGNAC, M., MAUGARD-LOUBOUTIN, C., SERIN, D., BLANC, B., ORSONI, P., and SOBOL, H. (1996). Attitudes towards cancer predictive testing and transmission of information to the family. J. Med. Genet. 33, 1-6.
15. JULIAN-REYNIER, C., SOBOL, H., SEVILLA, C., NOGUÈS, C., BOURRET, P., and the French Cancer Genetic Network. (2000a). Uptake of hereditary breast/ovarian cancer genetic testing in a french national sample of BRCA1 families. Psycho-Oncol. 9, 504-510.
16. JULIAN-REYNIER, C., EISINGER, F., CHABAL, F., LASSET, C., NOGUÈS, C., STOPPA-LYONNET, D., VENNIN, P., and SOBOL, H. (2000b). Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors. Am. J. Med. Genet. 94, 13-18.
17. KINNEY, A.Y., DEVELLIS, B.M., SKRZYNIA, C., and MILLIKAN, R. (2001). Genetic testing for colorectal carcinoma susceptibility-Focus group responses of individuals with colorectal carcinoma and first-degree relatives. Cancer 91, 57-65.
18. LERMAN, C., DALY, M., MASNY, A., and BALSHEM, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol. 12, 843-850.
19. LERMAN, C., SEAY, J., BALSHEM, A., and AUDRAIN, J. (1995). Interest in genetic testing among first degree relatives of breast cancer patients. Am. J. Med. Genet. 57, 385-392.
20. LERMAN, C., NAROD, S., SCHULMAN, K., HUGHES, C., GOMEZ-CAMINERO, A., BONNEY, G., GOLD, K., TROCK, B., MAIN, D., LYNCH, J., FULMORE, C., SNYDER, C., LEMON, S.J., CONWAY, T., TONIN, P., LENOIR, G., and LYNCH, H. (1996a). BRCA1 Testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J. Am. Med. Assn. 275, 1885-1892.
21. LERMAN, C., MARSHALL, J., AUDRAIN, J., and GOMEZ-CAMINERO, A. (1996b). Genetic testing for cancer colon susceptibility: anticipated reactions of patients and challenges to providers. Int. J. Cancer 69, 58-61.
22. MEIJERS-HEIJBOER, E.J., VERHOOG, L.C., BREKELMANS, C.T., SEYNAEVE, C., TILANUS-LINTHORST, M.M., WAGNER, A., DUKEL, L., DEVILEE, P., VAN DEN OUWELAND, A.M., VAN GEEL, A.N., and KLIJN, J.G. (2000). Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355, 2015-2020.
23. MIKI, Y., SWENSEN, J., SHATTUCK-EIDENS, D., FUTREAL, P.A., HARSHMAN, K., TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNETT, L.M., DING, W., BELL, R., ROSENTHAL, J., HUSSEY, C., TRAN, T., MCCLURE, M., FRYE, C., HATTIER, T., PHELPS, R., HAUGEN-STRANO, A., KATCHER, H., YAKUMO, K., GHOLAMI, Z., SHAFFER, D., STONE, S., BAYER, S., WRAY, C., BOGDEN, R., DAYANANTH, P., WARD, J., TONIN, P., NAROD, S., BRISTOW, P.K., NORRIS, F.H., HELVERING, L., ROSTECK, P., LAI, M., BARRETT, J.C., LEWIS, C., NEUHAUSEN, S., CANNON-ALBRIGHT, L., GOLDGAR, D., WISEMAN, R., KAMB, A., and SKOLNICK, M.H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
24. PRESS, N.A., YASUI, Y., REYNOLDS, S., DURFY, S.J., and BURKE, W. (2001). Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am. J. Med. Genet. 99, 99-110.
25. SAVULESCU, J., and MOMEYER, R.W. (1997). Should informed consent be based on rational beliefs? J. Med. Ethics 23, 282-288.
26. STOPPA-LYONNET, D., PUIG, P.L., ESSIOUX, L., PAGÈS, S., ITHIER, G., LIGOT, L., FOURQUET, A., SALMON, R.J., CLOUGH, K.B., POUILLART, P., the Institut Curie Breast Cancer Group, BONAÏTI-PELLIÉ, C., and THOMAS, G. (1997). BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am. J. Hum. Genet. 60, 1021-1030.
27. WAGNER, T., STOPPA-LYONNET, D., FLEISCHMANN, E., MUHR, D., PAGES, S., SANDBERG, T., CAUX, V., MOESLINGER, R., LANGBAUER, G., BORG, A., and OEFNER, P. (1999). Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62, 369-376.
28. WATSON, M., MURDAY, V., LLOYD, S., PONDER, B., AVERILL, D., and EELES, R. (1995). Genetic testing in breast/ovarian cancer (BRCA1) families. Lancet 346, 583.
29. WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGION, J., COLLINS, N., GREGORY, S., GUMBS, C., and MICKLEM, G. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.